Markets.News

BCRX  BIOCRYST PHARMACEUTICALS INC

+ add to watchlist

$9.05

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.

Mkt Cap: $2.29B

52 Week High: $11.31

P/E: -12.32

52 Week Low: $6.00

Dividend: $0.00

Shares Outstanding: 254.16M

This news is delayed by 15 minutes, sign up now to get live news & full features.